Related Experiment Videos
Summary
Metformin enhances insulin binding to its receptors in laboratory tests and in obese and type II diabetic patients. This improved insulin receptor capacity may restore insulin effectiveness in those with impaired responsiveness.
Area of Science:
- Pharmacology
- Endocrinology
- Cell Biology
Background:
- Metformin (N,N-dimethylbiguanide) is a less toxic biguanide compared to phenformin.
- Insulin resistance is a key feature of obesity and type II diabetes mellitus.
- Understanding metformin's mechanism of action on insulin signaling is crucial for diabetes management.
Purpose of the Study:
- To evaluate the effect of metformin on insulin binding to its receptors.
- To investigate whether metformin alters insulin receptor capacity or affinity.
- To determine if metformin's effect on insulin binding is related to circulating insulin levels.
Main Methods:
- In vitro assessment of 125I-insulin binding to IM-9 lymphocytes and MCF-7 cells after metformin preincubation.
- In vivo evaluation of 125I-insulin binding to monocytes in controls, obese, and type II diabetic subjects before and after metformin treatment.
- Scatchard analysis to determine changes in receptor binding parameters.
- Measurement of plasma insulin and blood glucose levels.
Main Results:
- Metformin significantly increased insulin binding in vitro to IM-9 lymphocytes (47.1%) and MCF-7 cells (38.0%).
- Metformin treatment significantly enhanced in vivo insulin binding to monocytes in obese subjects (+31%) and diabetic patients (+63%).
- Scatchard analysis revealed that increased binding was primarily due to enhanced receptor capacity, not affinity.
- Blood glucose levels significantly decreased in diabetic patients post-metformin treatment, while insulin levels remained unchanged across all groups.
Conclusions:
- Metformin enhances insulin binding to its receptors both in vitro and in vivo.
- The in vivo effect is observed in obese and type II diabetic individuals, correlating with metformin's clinical efficacy.
- The mechanism involves an increase in insulin receptor capacity, independent of circulating insulin levels.
- Metformin may improve insulin effectiveness in individuals with impaired insulin responsiveness by enhancing insulin receptor function.